Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
L. Alison Phillips, Lisa M. McAndrew & Benjamin Laman-Maharg. (2022) Symptom attribution to a medically unexplained syndrome is associated with greater perceived severity and bothersomeness of symptoms in US military veterans. Psychology & Health 37:11, pages 1342-1358.
Read now
Read now
Khaled Ezzedine, Anne Claire Fougerousse, Roberte Aubert, Jean-Benoît Monfort, Ziad Reguiaï, Jason Shourick, Charles Taieb & François Maccari. (2020) Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis. Clinical, Cosmetic and Investigational Dermatology 13, pages 325-332.
Read now
Read now
April W. Armstrong, Emily Edson-Heredia, April N. Naegeli, Russel Burge, Jiat-Ling Poon, Milena Anatchkova, Luna Sun, Baojin Zhu & Kathleen W. Wyrwich. (2020) Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses. Journal of Dermatological Treatment 31:5, pages 452-459.
Read now
Read now
Deeti J. Pithadia, Kelly A. Reynolds, Erica B. Lee & Jashin J. Wu. (2019) Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management. Journal of Dermatological Treatment 30:5, pages 435-440.
Read now
Read now
Kristen M. Beck & John Koo. (2019) Brodalumab for the treatment of plaque psoriasis: up-to-date. Expert Opinion on Biological Therapy 19:4, pages 287-292.
Read now
Read now
Jillian Frieder, Dario Kivelevitch, Connie Tran Fiore, Saadeddine Saad & Alan Menter. (2018) The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis. Expert Review of Clinical Immunology 14:1, pages 1-19.
Read now
Read now
Steven R. Feldman, Donald M. Bushnell, Paul A. Klekotka, Michael Scanlon, Mona L. Martin, Sally W. Wade, Wenjing Yang, Lionel Pinto, Leon Kircik & Hema N. Viswanathan. (2016) Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. Journal of Dermatological Treatment 27:3, pages 224-227.
Read now
Read now
Mona L. Martin, Kenneth Gordon, Lionel Pinto, Donald M. Bushnell, Dina Chau & Hema N. Viswanathan. (2015) The experience of pain and redness in patients with moderate to severe plaque psoriasis. Journal of Dermatological Treatment 26:5, pages 401-405.
Read now
Read now
Hema N. Viswanathan, Dina Chau, Cassandra E. Milmont, Wenjjing Yang, Ngozi Erondu, Dennis A. Revicki & Paul Klekotka. (2015) Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis. Journal of Dermatological Treatment 26:3, pages 235-239.
Read now
Read now
Reginald Villacorta, Joel W Hay & Andrew Messali. (2014) Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials. Expert Review of Pharmacoeconomics & Outcomes Research 14:4, pages 545-558.
Read now
Read now
Mona L. Martin, Kelly P. McCarrier, Chiun-Fang Chiou, Kenneth Gordon, Alexa B. Kimball, Abby S. Van Voorhees, Alice B. Gottlieb, Xingyue Huang, Denise Globe, Dina Chau, Hema N. Viswanathan & Gregory Kricorian. (2013) Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity. Journal of Dermatological Treatment 24:4, pages 255-260.
Read now
Read now
Articles from other publishers (40)
Dimitrios Rigopoulos, Charalampos Angelakopoulos, Zoi Apalla, Sophia Georgiou, Florentina Delli, Alexandros Drosos, Efterpi Zafiriou, John Katsantonis, Elisavet Lazaridou, Pantelis Panagakis, Evangelia Papadavid, Markos Papakonstantis, Angeliki‐Viktoria Roussaki‐Schulze, Elena Sotiriou, Georgios Anastasiadis, Eleftheria Tampouratzi, Vasiliki Chasapi, Konstantinos Sfaelos & Dimitrios Ioannides. (2022) Real world experience of brodalumab treatment in patients with moderate‐to‐severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study. Dermatologic Therapy 35:12.
Crossref
Crossref
Melissa Butt, James G. Marks & Alexandra Flamm. (2022) Establishing Consensus on the Treatment of Toxicodendron Dermatitis. Dermatitis 33:3, pages 220-226.
Crossref
Crossref
Georgios Kokolakis, Kasper Vadstrup, Jes B. Hansen & Jose Manuel Carrascosa. (2022) Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis. Dermatology 238:4, pages 620-629.
Crossref
Crossref
A. Jalili, P. Calzavara‐Pinton, L. Kircik, D. Lons‐Danic, A. Pink, S. Tyring, P. Cueva, M. Gooderham, S. Segaert, N. Nyholm, H. Thoning, B. Petersen & D. Thaçi. (2021)
Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A
post‐hoc
analysis of PSO‐LONG
. Journal of the European Academy of Dermatology and Venereology 36:1, pages 60-67.
Crossref
Crossref
Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani, Dario Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan & Alan Menter. (2021) Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology 84:2, pages 432-470.
Crossref
Crossref
Alice B. Gottlieb, Valerie Ciaravino, Christopher Cioffi, Luke Peterson & Richard B. Warren. (2020) Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis. Dermatology and Therapy 10:6, pages 1255-1272.
Crossref
Crossref
Jean-Philippe Lacour, Anthony Bewley, Edward Hammond, Jes B. Hansen, Laura Horne, Carle Paul, Kristian Reich, Julien Seneschal, Clara De Simone, Anne Sohrt, Matthias Augustin & Giovanni Pellacani. (2020) Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL). Dermatology and Therapy 10:5, pages 1099-1109.
Crossref
Crossref
Steven A. Svoboda, Rima I. Ghamrawi, Dorellie A. Owusu & Steven R. Feldman. (2020) Treatment Goals in Psoriasis: Which Outcomes Matter Most?. American Journal of Clinical Dermatology 21:4, pages 505-511.
Crossref
Crossref
S. Hsu, L.J. Green, M.G. Lebwohl, J.J. Wu, A. Blauvelt & A.A. Jacobson. (2019) Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials. British Journal of Dermatology 182:4, pages 880-888.
Crossref
Crossref
Bruce Strober, Peter C. M. van de Kerkhof, Kristina Callis Duffin, Yves Poulin, Richard B. Warren, Claudia de la Cruz, Joelle M. van der Walt, Bradley S. Stolshek, Mona L. Martin & Andre V. E. de Carvalho. (2019) Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council. American Journal of Clinical Dermatology 20:5, pages 699-709.
Crossref
Crossref
Amy McMichael, Seemal R. Desai, Aamir Qureshi, Shipra Rastogi & Andrew F. Alexis. (2018) Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials. American Journal of Clinical Dermatology 20:2, pages 267-276.
Crossref
Crossref
A.G. Ellis, C. Flohr & A.M. Drucker. (2018) Network meta‐analyses of systemic treatments for psoriasis: a critical appraisal. British Journal of Dermatology 180:2, pages 282-288.
Crossref
Crossref
A.B. Gottlieb, K. Gordon, S. Hsu, B. Elewski, L.F. Eichenfield, L. Kircik, S. Rastogi, R. Pillai & R. Israel. (2018) Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials. Journal of the European Academy of Dermatology and Venereology 32:8, pages 1305-1313.
Crossref
Crossref
Prashanth Sunkureddi, Stephen Doogan, John Heid, Samir Benosman, Alexis Ogdie, Layne Martin & Jacqueline B. Palmer. (2018) Evaluation of Self-reported Patient Experiences: Insights from Digital Patient Communities in Psoriatic Arthritis. The Journal of Rheumatology 45:5, pages 638-647.
Crossref
Crossref
Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M. Bartels, Ying Ying Leung, Niti Goel, Maarten de Wit, Dafna D. Gladman, Philip Mease, Lene Dreyer, Lars E. Kristensen, Oliver FitzGerald, William Tillett, Laure Gossec, Philip Helliwell, Vibeke Strand, Alexis Ogdie, Caroline B. Terwee & Robin Christensen. (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism 47:5, pages 654-665.
Crossref
Crossref
Dilek Solmaz, Lihi Eder & Sibel Zehra Aydin. (2018) Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis. Best Practice & Research Clinical Rheumatology 32:2, pages 295-311.
Crossref
Crossref
Alice B. Gottlieb, Brian Kirby, Caitriona Ryan, April N. Naegeli, Russel Burge, Alison Potts Bleakman, Milena D. Anatchkova & Gil Yosipovitch. (2017) The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS). Dermatology and Therapy 8:1, pages 45-56.
Crossref
Crossref
Kristina Callis Duffin. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology
7
25
.
A. M. Rentz, A. M. Skalicky, K. Burslem, K. Becker, D. Kaschinski, D. Esser & D. A. Revicki. (2017) The content validity of the PSS in patients with plaque psoriasis. Journal of Patient-Reported Outcomes 1:1.
Crossref
Crossref
Stéphanie Heyraud. (2017) Advancing Science: Driving Progress Today for a Clearer Tomorrow. EMJ Dermatology, pages 44-52.
Crossref
Crossref
Omid Roostaeyan, Dario Kivelevitch & Alan Menter. (2017) A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis. Immunotherapy 9:12, pages 963-978.
Crossref
Crossref
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, Chih-ho Hong, Ian Landells, Charles Lynde, Kim Papp, Yves Poulin, Ronald Vender & Marni C. Wiseman. (2017) Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition. Journal of Cutaneous Medicine and Surgery 21:2_suppl, pages 2S-40S.
Crossref
Crossref
Hema N. Viswanathan, Alex Mutebi, Cassandra E. Milmont, Kenneth Gordon, Hilary Wilson, Hao Zhang, Paul A. Klekotka, Dennis A. Revicki, Matthias Augustin, Gregory Kricorian, Ajay Nirula & Bruce Strober. (2017) Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis. Value in Health 20:8, pages 1174-1179.
Crossref
Crossref
Rana Abdat, Yeun Jina Lim, Deep Joshipura, Ari Goldminz & Alice Gottlieb. (2017) Patient-Reported Outcomes Measures in Psoriasis. Journal of Psoriasis and Psoriatic Arthritis 2:3, pages 41-46.
Crossref
Crossref
Dafna D. Gladman, Yves Poulin, Karen Adams, Marc Bourcier, Snezana Barac, Kirk Barber, Vinod Chandran, Jan Dutz, Cathy Flanagan, Melinda J. Gooderham, Wayne P. Gulliver, Vincent C. Ho, Chih-Ho Hong, Jacob Karsh, Majed M. Khraishi, Charles W. Lynde, Kim A. Papp, Proton Rahman, Sherry Rohekar, Cheryl F. Rosen, Anthony S. Russell, Ronald B. Vender, Jensen Yeung, Olga Ziouzina & Michel Zummer. (2017) Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. The Journal of Rheumatology 44:4, pages 519-534.
Crossref
Crossref
Bruce Strober, Alice B. Gottlieb, Bintu Sherif, Patrick Mollon, Isabelle Gilloteau, Lori McLeod, Todd Fox, Margaret Mordin, Ari Gnanasakthy, Charis Papavassilis & Mark G. Lebwohl. (2017) Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept. Journal of the American Academy of Dermatology 76:4, pages 655-661.
Crossref
Crossref
Umut Kalyoncu, Özün Bayindir, Mustafa Ferhat Öksüz, Atalay Doğru, Gezmiş Kimyon, Emine Figen Tarhan, Abdulsamet Erden, Şule Yavuz, Meryem Can, Gözde Yıldırım Çetin, Levent Kılıç, Orhan Küçükşahin, Ahmet Omma, Cem Ozisler, Dilek Solmaz, Emine Duygu Ersözlü Bozkirli, Lütfi Akyol, Seval Masatlıoğlu Pehlevan, Esen Kasapoglu Gunal, Fatos Arslan, Barış Yılmazer, Nilgun Atakan & Sibel Zehra Aydın. (2017) The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology 56:2, pages 279-286.
Crossref
Crossref
Jacqueline E. Greb, Ari M. Goldminz, James T. Elder, Mark G. Lebwohl, Dafna D. Gladman, Jashin J. Wu, Nehal N. Mehta, Andrew Y. Finlay & Alice B. Gottlieb. (2016) Psoriasis. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Andrew Y. Finlay. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
13
.
K.A. Papp, K. Reich, C. Paul, A. Blauvelt, W. Baran, C. Bolduc, D. Toth, R.G. Langley, J. Cather, A.B. Gottlieb, D. Thaçi, J.G. Krueger, C.B. Russell, C.E. Milmont, J. Li, P.A. Klekotka, G. Kricorian & A. Nirula. (2016) A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis. British Journal of Dermatology 175:2, pages 273-286.
Crossref
Crossref
Ana-Maria Orbai & Alexis Ogdie. (2016) Patient-Reported Outcomes in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 42:2, pages 265-283.
Crossref
Crossref
Philip J. Mease, Mark C. Genovese, Alex Mutebi, Hema N. Viswanathan, Dina Chau, Jingyuan Feng, Ngozi Erondu & Ajay Nirula. (2016) Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis. The Journal of Rheumatology 43:2, pages 343-349.
Crossref
Crossref
Hilary D. Wilson, Alex Mutebi, Dennis A. Revicki, Philip J. Mease, Mark C. Genovese, Ngozi Erondu, Ajay Nirula, Feng Jing Yuan & Hema N. Viswanathan. (2015) Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis. Arthritis Care & Research 67:12, pages 1750-1756.
Crossref
Crossref
Philip J. Mease. (2015) The Psoriasis Symptom Inventory: An Effective Patient-reported Outcome Measure of Psoriasis Severity. The Journal of Rheumatology 42:6, pages 1034-1036.
Crossref
Crossref
H. Kitchen, L. Cordingley, H. Young, C.E.M. Griffiths & C. Bundy. (2015) Patient-reported outcome measures in psoriasis: the good, the bad and the missing!. British Journal of Dermatology 172:5, pages 1210-1221.
Crossref
Crossref
Alexandra Price & David E. Cohen. (2014) Assessment of Pruritus in Patients With Psoriasis and Atopic Dermatitis. Dermatitis 25:6, pages 334-344.
Crossref
Crossref
Philip J. Mease, Mark C. Genovese, Maria W. Greenwald, Christopher T. Ritchlin, André D. Beaulieu, Atul Deodhar, Richard Newmark, JingYuan Feng, Ngozi Erondu & Ajay Nirula. (2014) Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis. New England Journal of Medicine 370:24, pages 2295-2306.
Crossref
Crossref
Donald M. Bushnell, Mona L. Martin, Michael Scanlon, TeChieh Chen, Dina Chau & Hema N. Viswanathan. (2013) Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory. Quality of Life Research 23:3, pages 897-906.
Crossref
Crossref
K.B. Gordon, A.B. Kimball, D. Chau, H.N. Viswanathan, J. Li, D.A. Revicki, G. Kricorian & B.G. Ortmeier. (2014) Impact of brodalumab treatment on psoriasis symptoms and health‐related quality of life: use of a novel patient‐reported outcome measure, the Psoriasis Symptom Inventory. British Journal of Dermatology 170:3, pages 705-715.
Crossref
Crossref
Alice B. Gottlieb & April W. Armstrong. (2013) Psoriasis Outcome Measures: A Report from the GRAPPA 2012 Annual Meeting. The Journal of Rheumatology 40:8, pages 1428-1433.
Crossref
Crossref